Protein detail

MDR3

Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3)

Entry name
MDR3
UniProt ID
EVMP confidence score
0.50
Supporting publications (n)
4
Transmembrane count
12
Protein classification
Disease related genesEnzymesHuman disease related genesMetabolic proteinsPlasma proteinsPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information13
Protein Names
Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3)
Protein Class (9)
Disease related genesEnzymesHuman disease related genesMetabolic proteinsPlasma proteinsPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters
Protein Function (7)
  • Predicted intracellular proteins
  • Human disease related genes:Digestive system diseases:Liver diseases
  • Potential drug targets
  • Enzymes
  • ENZYME proteins
  • Transporters:Primary Active Transporters
  • Disease related genes
Transmembrane
51..73; Helical; 119..139; Helical; 189..210; Helical; 218..238; Helical; 297..318; Helical; 333..354; Helical; 712..732; Helical; 756..776; Helical; 832..852; Helical; 854..873; Helical; 934..956; Helical; 973..994; Helical
Transmembrane Count
12
Entrez Gene Symbol
Gene Synonym (5)
GBD1MDR2MDR3PFIC-3PGY3
Gene Description
ATP binding cassette subfamily B member 4
Chromosome
7
Position
87401696-87480435
Supporting publications (n)
4
EVMP confidence score
0.50
Function & Pathway8
Protein Function (7)
  • Predicted intracellular proteins
  • Human disease related genes:Digestive system diseases:Liver diseases
  • Potential drug targets
  • Enzymes
  • ENZYME proteins
  • Transporters:Primary Active Transporters
  • Disease related genes
Canonical Pathways (3)
  • M290 Pid il12 stat4 pathway
  • M54 Pid il12 2pathway
  • M34 Pid tcr pathway
Mediation Categories (4)
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationMetabolism mediation
Relations & Evidence27

Ligand-Receptor Signaling (26)

26 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
apical_cell_membraneplasma_membraneUniProt_locationNoNoNoNoNo
plasma_membraneplasma_membraneOmniPathNoNoNoNoNo
cell_surfacecell_surfaceSurfaceomeNoNoNoNoNo
cell_surfacecell_surfaceOmniPathNoNoNoNoNo
receptorreceptorscConnectNoYesNoNoNo
transmembranetransmembrane_predictedPhobiusNoNoNoNoNo
Page 3 of 3Previous

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyImmunoaffinity CaptureMass spectrometry23811336841307968
Sequence, Structure & Domains13

Sequences

Length
1,286
Mass
141,523
Sequence
MDLEAAKNGTAWRPTSAEGDFELGISSKQKRKKTKTVKMIGVLTLFRYSDWQDKLFMSLGTIMAIAHGSGLPLMMIVFGEMTDKFVDTAGNFSFPVNFSLSLLNPGKILEEEMTRYAYYYSGLGAGVLVAAYIQVSFWTLAAGRQIRKIRQKFFHAILRQEIGWFDINDTTELNTRLTDDISKISEGIGDKVGMFFQAVATFFAGFIVGFIRGWKLTLVIMAISPILGLSAAVWAKILSAFSDKELAAYAKAGAVAEEALGAIRTVIAFGGQNKELERYQKHLENAKEIGIKKAISANISMGIAFLLIYASYALAFWYGSTLVISKEYTIGNAMTVFFSILIGAFSVGQAAPCIDAFANARGAAYVIFDIIDNNPKIDSFSERGHKPDSIKGNLEFNDVHFSYPSRANVKILKGLNLKVQSGQTVALVGSSGCGKSTTVQLIQRLYDPDEGTINIDGQDIRNFNVNYLREIIGVVSQEPVLFSTTIAENICYGRGNVTMDEIKKAVKEANAYEFIMKLPQKFDTLVGERGAQLSGGQKQRIAIARALVRNPKILLLDEATSALDTESEAEVQAALDKAREGRTTIVIAHRLSTVRNADVIAGFEDGVIVEQGSHSELMKKEGVYFKLVNMQTSGSQIQSEEFELNDEKAATRMAPNGWKSRLFRHSTQKNLKNSQMCQKSLDVETDGLEANVPPVSFLKVLKLNKTEWPYFVVGTVCAIANGGLQPAFSVIFSEIIAIFGPGDDAVKQQKCNIFSLIFLFLGIISFFTFFLQGFTFGKAGEILTRRLRSMAFKAMLRQDMSWFDDHKNSTGALSTRLATDAAQVQGATGTRLALIAQNIANLGTGIIISFIYGWQLTLLLLAVVPIIAVSGIVEMKLLAGNAKRDKKELEAAGKIATEAIENIRTVVSLTQERKFESMYVEKLYGPYRNSVQKAHIYGITFSISQAFMYFSYAGCFRFGAYLIVNGHMRFRDVILVFSAIVFGAVALGHASSFAPDYAKAKLSAAHLFMLFERQPLIDSYSEEGLKPDKFEGNITFNEVVFNYPTRANVPVLQGLSLEVKKGQTLALVGSSGCGKSTVVQLLERFYDPLAGTVFVDFGFQLLDGQEAKKLNVQWLRAQLGIVSQEPILFDCSIAENIAYGDNSRVVSQDEIVSAAKAANIHPFIETLPHKYETRVGDKGTQLSGGQKQRIAIARALIRQPQILLLDEATSALDTESEKVVQEALDKAREGRTCIVIAHRLSTIQNADLIVVFQNGRVKEHGTHQQLLAQKGIYFSMVSVQAGTQNL
Alternative Products
Event=Alternative splicing; Named isoforms=3; Name=1; IsoId=P21439-1; Sequence=Displayed; Name=2; IsoId=P21439-2; Sequence=VSP_023263; Name=3; IsoId=P21439-3; Sequence=VSP_046258, VSP_023263
Alternative Sequence
929..975; Missing (in isoform 3); 1094..1100; Missing (in isoform 2 and isoform 3)

3D Structural Models

Turn
45..48; 619..621; 1045..1048; 1107..1109; 1240..1245
Helix
51..68; 70..73; 75..78; 108..159; 162..167; 173..187; 190..212; 214..221; 224..261; 263..268; 272..324; 330..349; 351..372; 435..442; 460..462; 465..471; 486..494; 499..508; 512..517; 521..523; 528..530; 535..547; 565..578; 614..618; 623..628; 697..700; 708..722; 724..738; 747..795; 800..804; 810..828; 831..852; 854..860; 861..863; 864..901; 903..909; 912..965; 970..1012; 1075..1083; 1112..1117; 1133..1138; 1148..1157; 1161..1166; 1177..1179; 1184..1196; 1214..1227
Beta Strand
394..398; 404..406; 424..428; 452..455; 472..475; 483..485; 518..520; 552..558; 583..587; 598..604; 607..612; 739..742; 744..746; 796..798; 1034..1038; 1051..1053; 1056..1059; 1064..1068; 1119..1122; 1130..1132; 1167..1171; 1201..1207; 1209..1212; 1231..1236; 1247..1253
3D Structure
Electron microscopy (4)

Domain & Motif Annotations

Domain (FT)
57..359; ABC transmembrane type-1 1; 394..630; ABC transporter 1; 711..999; ABC transmembrane type-1 2; 1034..1279; ABC transporter 2
Region
625..647; Interaction with HAX1
Protein Families (3)
  • ABC transporter superfamily
  • ABCB family
  • Multidrug resistance exporter (TC 3.A.1.201) subfamily
Sequence Similarities
Belongs to the ABC transporter superfamily. ABCB family. Multidrug resistance exporter (TC 3.A.1.201) subfamily.
Clinical Relevance6
Disease Involvement (2)
Disease variantIntrahepatic cholestasis
Biomarker
Discontinued in Phase 3; Phase 2
Drug Targets
Clinical trial target
Supporting Publications4
PMIDTitleAbstract
26538482Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles.No abstract available
37862381Surfaceome analysis of extracellular vesicles from senescent cells uncovers uptake repressor DPP4.No abstract available
38731868The Deep Proteomics Approach Identified Extracellular Vesicular Proteins Correlated to Extracellular Matrix in Type One and Two Endometrial Cancer.No abstract available
38937789The RNA binding protein IGF2BP2/IMP2 alters the cargo of cancer cell-derived extracellular vesicles supporting tumor-associated macrophages.No abstract available